Refresh

This website neurosciencenews.com/neuroscience-terms/neurotech/ is currently offline. Cloudflare's Always Online™ shows a snapshot of this web page from the Internet Archive's Wayback Machine. To check for the live version, click Refresh.

Neurotechnology Research

A new study has revealed a link between sunlight exposure, physical activity, and depression using wrist-based activity sensors. Over two weeks, researchers found that individuals with depression had lower physical activity levels, especially in shorter daylight periods, compared to those without depression.
A new study suggests that neurostimulation targeting specific brain circuits may help treat PTSD in veterans. Researchers found that veterans with damage to brain areas connected to the amygdala, the brain's fear center, were less likely to develop PTSD.
A new study compared two advanced imaging methods, dMRI-based tractography and PS-OCT, to map nerve fiber orientations in the human brainstem. The findings suggest that combining these techniques could enhance our understanding of brain microstructure, which may lead to early detection of neurodegenerative diseases.
Researchers have developed a novel optical sensor that can detect dopamine directly from unprocessed blood samples. This sensor, using a synthetic DNA strand called an aptamer, identifies dopamine with high precision, making it a potential tool for diagnosing cancers and neurological disorders.
Adaptive VR exergames, which adjust difficulty based on a user's emotional state, can improve exercise adherence and enjoyment. By using sensors to monitor physiological changes like heart rate and facial expressions, these games can dynamically respond to how a person feels, keeping them engaged longer.

Brain Computer Interface news involves science using BCI, neural interfaces, brain implant technologies, EEG control of robotics, neurobotics and more.

Researchers enabled a silent person to produce speech using thought alone. Depth electrodes in the participant's brain transmitted electrical signals to a computer, which then vocalized imagined syllables. This technology offers hope for paralyzed individuals to regain speech. The study marks a significant step towards brain-computer interfaces for voluntary communication.
Researchers are trialing a novel brain-computer interface (BCI) with the potential to transform neurosurgical procedures and patient care. The Layer 7 Cortical Interface, boasting 1,024 electrodes for unparalleled brain activity mapping, promises new insights into neurological and psychiatric conditions.
Elon Musk announces the first human has been successfully implanted with Neuralink's brain chip, named Telepathy, aiming to allow severe physically disabled individuals to control devices via thought. The FDA-approved trial focuses on the implant's potential for movement control, with the patient reportedly recovering well and showing promising initial results.
Researchers achieved a breakthrough in converting brain signals to audible speech with up to 100% accuracy. The team used brain implants and artificial intelligence to directly map brain activity to speech in patients with epilepsy.
In a pioneering study, researchers designed a wireless brain-spine interface enabling a paralyzed man to walk naturally again. The 'digital bridge' comprises two electronic implants — one on the brain and another on the spinal cord — that decode brain signals and stimulate the spinal cord to activate leg muscles.

The latest science news involving neural prosthetics, arm and leg prostheses, bionics, biomechanical engineering, BCIs, robotics, EEG control of prosthetics, visual aids, auditory aids for hearing and more is here. You can also

A new neuroprosthetic interface allows prosthetic limbs to be controlled by the body's nervous system, resulting in a natural walking gait. The surgery reconnects muscles, providing proprioceptive feedback, enabling users to walk faster and navigate obstacles more effectively.

More Neurotech News

Browse all of our neurotechnology articles over the years. Remember you can click on the tags or search for specific articles.

This shows blood samples.
Researchers have developed an innovative device that can diagnose glioblastoma, an aggressive brain cancer, in under an hour using a novel biochip. The chip leverages electrokinetic technology to detect active Epidermal Growth Factor Receptors (EGFRs) in extracellular vesicles from a small blood sample. This method offers high sensitivity and selectivity, minimizing interference and potentially improving early detection. The technology could be adapted for diagnosing other diseases, enhancing its clinical impact.
This shows the BMI chip.
Researchers developed a compact, low-power brain-machine interface (BMI) called MiBMI, designed to enhance communication for individuals with severe motor impairments. The device translates neural activity into text with 91% accuracy, using a highly miniaturized system that processes data in real-time. This innovation opens the door to practical, implantable BMIs, promising significant improvements in quality of life for patients with conditions like ALS and spinal cord injuries.
This shows a person in an EEG cap.
A century after the first human brainwave recording, EEG technology has revolutionized our understanding of brain function, particularly in diagnosing epilepsy. Experts now predict that within a generation, EEG could become a widespread tool for cognitive enhancement, early diagnosis, and communication for those with severe disabilities. However, ethical concerns about privacy and the commercialization of EEG data loom large as the technology advances.
This shows a brain and sound waves.
A new study finds that 40Hz light and sound therapy helps maintain myelin, a crucial brain structure, in Alzheimer's patients. This therapy, which protects neurons and supports brain function, could offer new treatment avenues for neurodegenerative diseases. Researchers discovered that this stimulation enhances neural connections and reduces harmful inflammation. The therapy also shows potential for treating other conditions involving myelin loss, such as multiple sclerosis.
This shows a brain.
Researchers genetically engineered the parasite Toxoplasma gondii to deliver drugs across the blood-brain barrier. This innovative approach has been used to deliver therapeutic proteins to neurons, showing promise for treating neurological conditions like Rett syndrome. The research highlights the potential for parasites to act as delivery vehicles for large molecules that typically struggle to penetrate the brain. This breakthrough could lead to new treatments for a variety of neurological disorders.
This shows a psychedelic brain.
Researchers developed a rapid, noninvasive tool called CaST that tracks neurons and biomolecules activated by psychedelic drugs. This new method allows researchers to observe the cellular processes responsible for the neuroplastic effects of psychedelics, offering insights into treatments for brain disorders like depression and PTSD.
This shows a model of a head and neurons.
Researchers discovered a neural activity pattern that can accurately predict and monitor the clinical status of OCD patients undergoing deep brain stimulation (DBS). The study highlights how this biomarker can guide DBS therapy, improving treatment outcomes for those with severe, treatment-resistant OCD.
This shows a depressed woman.
Researchers reveal how targeting transcranial magnetic stimulation (TMS) could enhance treatment for depression. The study identified an electrophysiological marker that could predict TMS efficacy and guide personalized therapy. By optimizing the stimulation site and coil angle, treatment outcomes may improve. These findings offer hope for better, tailored TMS therapies in the future.
This shows a brain.
A groundbreaking implantable device has significantly reduced the frequency and severity of seizures in children with severe epilepsy, according to a new UK clinical trial. The rechargeable device, attached to the skull, delivers constant electrical stimulation to the brain, allowing patients like Oran to experience dramatic improvements in quality of life. This trial, known as the CADET pilot, is the first to measure this treatment for pediatric epilepsy and shows promise for broader applications. Further research will expand to more patients, aiming for a new standard in epilepsy treatment.
This shows cells.
Advances in organoids and embryonic models raise questions about human individuality. A new study argues these models can reinforce, not weaken, the concept of human individuality when viewed through personhood and sentience frameworks. Researchers emphasize that current technologies are far from achieving personhood in embryo models or organoids. The ethical focus should remain on the wellbeing of actual persons and sentient beings.
This shows a robot in a house.
esearchers have developed an AI system that guides robots using language-based instructions, improving navigation tasks without relying on extensive visual data. This method converts visual observations into text captions, allowing a language model to direct the robot's movements. While not outperforming vision-based systems, it excels in data-limited scenarios and combines well with visual inputs for better performance.